BioCentury
ARTICLE | Clinical News

MVA F6 HIV- Nef: Began Phase I/II study

February 22, 2000 8:00 AM UTC

Bavarian Nordic Research Institute A/S (CSE:BNRI), Glostrup, Denmark Product: MVA F6 HIV- Nef Business: Infectious diseases Therapeutic category: Gene therapy, Immune stimulation Target: Cytotoxic T l...